Diamond Biofund Inc. (TPE:6901)

Market Cap	15.10B -5.4%
Revenue (ttm)	3.02B
Net Income	2.92B
EPS	3.39
Shares Out	853.36M
PE Ratio	5.22
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,041,433
Open	17.50
Previous Close	17.15
Day's Range	17.40 - 18.30
52-Week Range	12.05 - 22.40
Beta	0.93
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 10, 2026

About Diamond Biofund

Diamond Biofund Inc. is a venture capital firm specializing in evergreen funds. The firm seeks investment in start-ups and early ventures. It typically invests in biotechnology and medical investments, including new drug R&D, high-end medical equipment, innovative medical services and channels, and agricultural biotechnology. Diamond Biofund Inc. was founded in 2013 and is based in Taipei, Taiwan.

• Industry: Asset Management
• Sector: Financials
• Founded: 2013
• Employees: 29
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6901

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 9, 2026

Data Sources Report a data error